LobbyingCarda Health lobbying by quarter
Carda Health's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q1 2025; the issues it reports most are Medicare/Medicaid.
Carda Health
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $60K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2025 | $20K | 1 |
| Q2 2025 | $20K | 1 |
| Q3 2025 | $20K | 1 |
| Q4 2025 | $20K | 1 |
| Q1 2026 | $20K | 1 |
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Medicare and Medicaid$120K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES6 reports
- SENATE6 reports
- Centers For Medicare and Medicaid Services (CMS)5 reports
- Health & Human Services, Dept of (HHS)5 reports
Firms it paid
| Firm | ||
|---|---|---|
| McDermott+ | $120K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DEBRA CURTIS | 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee | Q2 2026 |
| JOSH JORGENSEN | 2017-2020: Senior Legislative Correspondent; Legislative Aide, Sen. Mike Rounds | Q2 2026 |
| JULIA GRABO | 2021: Paid Intern, Rep. Colin Allred | Q2 2026 |
| RODNEY WHITLOCK | 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood | Q2 2026 |
| LEIGH FELDMAN | 2016-2017: Senate Finance Committee (Detailee) | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/06for Q2 | McDermott+ | $20K |
| 04/13for Q1 | McDermott+ | $20K |
| 01/08for Q4 2025 | McDermott+ | $20K |
| 25/10/13for Q3 2025 | McDermott+ | $20K |
| 25/07/14for Q2 2025 | McDermott+ | $20K |
| 25/04/10for Q1 2025 | McDermott+ | $20K |
| 25/04/01for Q1 2025 | McDermott+ | Under $5,000 |